Withdrawal syndrome.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry; D007783:Lactones / Q000009:adverse effects*; D040541:Marketing; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib